Summary
There is an ongoing shortage of critical chemotherapy drugs like cisplatin and carboplatin, which are essential for treating various cancers. This shortage, which has worsened since 2023, is primarily due to economic factors, including hospitals seeking the lowest prices for generic drugs, making it unprofitable for manufacturers to produce them.